This National Consensus Statement is meant to be used as an advocacy tool to ensure the specific HIV research priorities of women, trans people and girls are included in the next generation of HIV and AIDS research responses undertaken in Canada.
Publication Categories
Archives(2)
Combination Prevention(26)
Community and Health Systems Strengthening(9)
HIV and Co-infections(4)
Key Populations and Vulnerable Groups(19)
Public Policy and Global Engagement(11)
Reproductive, Maternal, Newborn and Child Health (RMNCH)(1)
Social Determinants of Health(15)
Toolkits(7)
Twinning(6)
Sort by:
Women
Related Content:
Statement: European Medicine’s Agency Positive Opinion on Dapivirine Ring is a Turning Point towards Women-centred HIV Prevention July 24, 2020 FOR IMMEDIATE RELEASE 24 July 2020 (Ottawa, ON) – ICAD congratulates the International Partnership on Microbicides (IPM) on its announcement today that the European Medicine’s Agency (EMA) has issued a…- Recording - The MSAFIRI Post Migration Health Project June 13, 2018 The "Understanding HIV Transmission in African, Caribbean and Black (ACB) Communities Following Arrival in Canada Study" or MSAFIRI project was implemented between 2014 - 2017 with aim of shedding light…
Closing the Gap? Cut the Crap! December 4, 2018 New Research Priorities from the US National Institutes of Health (NIH) Restricts Prevention OptionsBy Marc-André LeBlanc, Founding member of IRMA International Rectal Microbicide Advocates (IRMA) and our many partners and…
Project Overview: Towards reducing the impact of HIV for women of reproductive age living with HIV and children under five living with or affected by HIV November 5, 2020 PARTNERS PROJECT OVERVIEWThe Coalition of Women Living with HIV/AIDS (COWLHA) (Malawi), the Coalition for the Empowerment of Women and Girls (CEWAG) (Malawi) and the Program for Vulnerable Women and…- African, Caribbean and Black Canadian HIV/AIDS Awareness Day February 1, 2019 The Canadian HIV/AIDS Black, African and Caribbean Network (CHABAC) would like to announce the fifth annual African, Caribbean and Black Canadian HIV/AIDS Awareness Day on February 7, 2019 to help…
- Interim Results of Open-Label Study of IPM’s Dapivirine Vaginal Ring Find Increased Product Use and Suggest Greater HIV Risk Reduction [IPM] March 6, 2018 Compared to earlier Phase III study, women’s adherence to monthly HIV prevention ring is higher and data suggest infection rates are lower.